Medroxyprogesterone Acetate 150 mg/mL

Medroxyprogesterone Acetate 150 mg/mL is an extended-release injectable suspension used for contraception and hormone therapy. This medication is designed for intramuscular administration and is manufactured by Amphastar Pharmaceuticals, Inc.

Medroxyprogesterone Acetate is primarily used for long-term contraception and hormone replacement therapy. It works by altering the menstrual cycle to prevent ovulation, making it a popular choice for birth control. Additionally, it may be prescribed to manage certain hormonal imbalances or conditions related to the reproductive system.

Common effects of Medroxyprogesterone Acetate may include changes in menstrual bleeding patterns, such as irregular periods or spotting. Some users may experience weight gain, headaches, or mood changes. These effects can vary widely among individuals and typically subside as the body adjusts to the medication.

Medroxyprogesterone Acetate should be used with caution, especially in individuals with a history of blood clots, liver disease, or breast cancer. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to ensure safety and effectiveness.

Medroxyprogesterone Acetate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.